Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project

Kristin A. Guertin,David R. Repaske,Julia F. Taylor,Eli S. Williams,Suna Onengut-Gumuscu,Wei-Min Chen,Sarah R. Boggs,Liping Yu,Luke Allen,Lacey Botteon,Louis Daniel,Katherine G. Keating,Mika K. Labergerie,Tyler S. Lienhart,Jorge A. Gonzalez-Mejia,Matt J. Starnowski,Stephen S. Rich
DOI: https://doi.org/10.1186/s13073-024-01305-8
IF: 15.266
2024-02-16
Genome Medicine
Abstract:Population screening for risk of type 1 diabetes (T1D) has been proposed to identify those with islet autoimmunity (presence of islet autoantibodies). As islet autoantibodies can be transient, screening with a genetic risk score has been proposed as an entry into autoantibody testing.
genetics & heredity
What problem does this paper attempt to address?